DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2010 archives
Click here to return to the current data set

DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.

Generic Name: kanamycin sulfate

Summary for Generic Name: kanamycin sulfate

Tradenames:4
Patents:0
Applicants:11
NDAs:20
Drug Master File Entries: see list4
Therapeutic Class:Antibacterials

Clinical Trials for: kanamycin sulfate

Trial of Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery: Oral and Systemic Versus Systemic Antibiotics
Status: Completed Condition: Colorectal Neoplasms

High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis
Status: Completed Condition: Tuberculosis, Multidrug-Resistant

Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease
Status: Active, not recruiting Condition: Mycobacterium Avium-Intracellulare Infection

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis
Status: Temporarily not available Condition: Tuberculosis

Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis
Status: Recruiting Condition: Tuberculosis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist_Flag Patent Expiration Exclusivity Expiration
King Pharms
KLEBCIL
kanamycin sulfate
INJECTABLE; INJECTION062170Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Apothecon
KANTREX
kanamycin sulfate
INJECTABLE; INJECTION062564Sep 21, 1984DISCNNo<disabled><disabled>
Apothecon
KANTREX
kanamycin sulfate
INJECTABLE; INJECTION061901Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Apothecon
KANTREX
kanamycin sulfate
INJECTABLE; INJECTION061655Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Sign up for a free trial

First name
Last name
Email address

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639

`abc